-
Je něco špatně v tomto záznamu ?
Immune Response 5-7 Months after Vaccination against SARS-CoV-2 in Elderly Nursing Home Residents in the Czech Republic: Comparison of Three Vaccines
J. Martínek, H. Tomášková, J. Janošek, H. Zelená, A. Kloudová, J. Mrázek, E. Ježo, V. Král, J. Pohořská, H. Šturcová, R. Maďar
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
35632827
DOI
10.3390/v14051086
Knihovny.cz E-zdroje
- MeSH
- COVID-19 * epidemiologie prevence a kontrola MeSH
- imunita MeSH
- imunoglobulin G MeSH
- lidé MeSH
- pečovatelské domovy MeSH
- SARS-CoV-2 MeSH
- senioři MeSH
- vakcinace MeSH
- vakcíny * MeSH
- Check Tag
- lidé MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND AND AIMS: Elderly nursing home residents are especially prone to a severe course of SARS-CoV-2 infection. In this study, we aimed to investigate the complex immune response after vaccination depending on the convalescence status and vaccine. METHODS: Sampling took place in September-October 2021. IgG antibodies against spike protein and nucleocapsid protein, the titer of virus neutralization antibodies against delta and (on a subset of patients) omicron, and cellular immunity (interferon-gamma release assay) were tested in nursing home residents vaccinated with Pfizer, Moderna (both 30-31 weeks after the completion of vaccination), or AstraZeneca (23 weeks) vaccines. The prevalence with 95% confidence intervals (CI) was evaluated in Stata version 17. RESULTS: 95.2% (95% CI: 92.5-97.1%) of the 375 participants had positive results of anti-S IgG, 92.8% (95% CI: 89.7-95.2%) were positive in virus neutralization assay against delta, and 89.0% (95% CI: 84.5-92.5%) in the interferon-gamma-releasing assay detecting cellular immunity. Results of the virus neutralization assay against omicron correlated with those against delta but the neutralization capacity was reduced by about half. As expected, the worst results were found for the AstraZeneca vaccine, although the vaccination-to-test period was the shortest for this vaccine. All immune parameters were significantly higher in convalescent residents than in naive residents after vaccination. No case of COVID-19 occurred during the vaccination-to-test period. CONCLUSIONS: A high immune response, especially among vaccinated convalescents (i.e., residents with hybrid immunity), was found in elderly nursing home residents 5-7 months after vaccination against SARS-CoV-2. In view of this, it appears that such residents are much better protected from COVID-19 than those who are only vaccinated and the matter of individual approach to the booster dose in such individuals should be further discussed.
Institute of Public Health Ostrava Partyzánské náměstí 7 702 00 Ostrava Czech Republic
Institute of Public Health Ústí nad Labem Moskevská 1531 15 400 01 Ústí nad Labem Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018381
- 003
- CZ-PrNML
- 005
- 20220804134734.0
- 007
- ta
- 008
- 220720s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/v14051086 $2 doi
- 035 __
- $a (PubMed)35632827
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Martínek, Jan $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic $1 https://orcid.org/0000000168697391
- 245 10
- $a Immune Response 5-7 Months after Vaccination against SARS-CoV-2 in Elderly Nursing Home Residents in the Czech Republic: Comparison of Three Vaccines / $c J. Martínek, H. Tomášková, J. Janošek, H. Zelená, A. Kloudová, J. Mrázek, E. Ježo, V. Král, J. Pohořská, H. Šturcová, R. Maďar
- 520 9_
- $a BACKGROUND AND AIMS: Elderly nursing home residents are especially prone to a severe course of SARS-CoV-2 infection. In this study, we aimed to investigate the complex immune response after vaccination depending on the convalescence status and vaccine. METHODS: Sampling took place in September-October 2021. IgG antibodies against spike protein and nucleocapsid protein, the titer of virus neutralization antibodies against delta and (on a subset of patients) omicron, and cellular immunity (interferon-gamma release assay) were tested in nursing home residents vaccinated with Pfizer, Moderna (both 30-31 weeks after the completion of vaccination), or AstraZeneca (23 weeks) vaccines. The prevalence with 95% confidence intervals (CI) was evaluated in Stata version 17. RESULTS: 95.2% (95% CI: 92.5-97.1%) of the 375 participants had positive results of anti-S IgG, 92.8% (95% CI: 89.7-95.2%) were positive in virus neutralization assay against delta, and 89.0% (95% CI: 84.5-92.5%) in the interferon-gamma-releasing assay detecting cellular immunity. Results of the virus neutralization assay against omicron correlated with those against delta but the neutralization capacity was reduced by about half. As expected, the worst results were found for the AstraZeneca vaccine, although the vaccination-to-test period was the shortest for this vaccine. All immune parameters were significantly higher in convalescent residents than in naive residents after vaccination. No case of COVID-19 occurred during the vaccination-to-test period. CONCLUSIONS: A high immune response, especially among vaccinated convalescents (i.e., residents with hybrid immunity), was found in elderly nursing home residents 5-7 months after vaccination against SARS-CoV-2. In view of this, it appears that such residents are much better protected from COVID-19 than those who are only vaccinated and the matter of individual approach to the booster dose in such individuals should be further discussed.
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a COVID-19 $x epidemiologie $x prevence a kontrola $7 D000086382
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunita $7 D007109
- 650 _2
- $a imunoglobulin G $7 D007074
- 650 _2
- $a pečovatelské domovy $7 D009735
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 650 _2
- $a vakcinace $7 D014611
- 650 12
- $a vakcíny $7 D014612
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Tomášková, Hana $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic $1 https://orcid.org/0000000296081276 $7 pna2008424773
- 700 1_
- $a Janošek, Jaroslav $u Centre for Health Research, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic $1 https://orcid.org/0000000306824521
- 700 1_
- $a Zelená, Hana $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
- 700 1_
- $a Kloudová, Alena $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
- 700 1_
- $a Mrázek, Jakub $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
- 700 1_
- $a Ježo, Eduard $u Institute of Public Health Ostrava, Partyzánské náměstí 7, 702 00 Ostrava, Czech Republic
- 700 1_
- $a Král, Vlastimil $u Institute of Public Health Ústí nad Labem, Moskevská 1531/15, 400 01 Ústí nad Labem, Czech Republic
- 700 1_
- $a Pohořská, Jitka $u Institute of Public Health Ústí nad Labem, Moskevská 1531/15, 400 01 Ústí nad Labem, Czech Republic
- 700 1_
- $a Šturcová, Hana $u Institute of Public Health Ústí nad Labem, Moskevská 1531/15, 400 01 Ústí nad Labem, Czech Republic
- 700 1_
- $a Maďar, Rastislav $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Syllabova 19, 703 00 Ostrava, Czech Republic
- 773 0_
- $w MED00177099 $t Viruses $x 1999-4915 $g Roč. 14, č. 5 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35632827 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134728 $b ABA008
- 999 __
- $a ok $b bmc $g 1822127 $s 1169624
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 14 $c 5 $e 20220518 $i 1999-4915 $m Viruses $n Viruses $x MED00177099
- LZP __
- $a Pubmed-20220720